Fosun Pharma

Fosun Pharma, established in 1994 and headquartered in Shanghai, China, is a prominent entity within the Pharmaceuticals and Healthcare industries. The company dedicates its operations to the research and development and manufacturing of pharmaceuticals, focusing on innovation-driven approaches. Its core business encompasses a wide array of healthcare products and services, including pharmaceuticals, generic drugs, and integrated healthcare solutions. Fosun Pharma leverages its technology platforms to advance novel therapies and molecules, aiming to address critical medical needs across various therapeutic areas.

With a significant global presence, Fosun Pharma operates with a substantial workforce, employing Over 10,000 employees. This extensive team supports its broad operational scope, which includes extensive R&D initiatives and manufacturing capabilities. The company's commitment to innovation is reflected in its product pipeline and strategic focus on developing treatments for diseases, particularly in oncology and blood systems. For insights into the people driving these advancements, consider Meet Fosun Pharma's team.

The company competes in a dynamic global market against major players such as Shanghai Pharmaceuticals, Sun Pharma, and Otsuka Holdings. Fosun Pharma's revenue reached $5.7B, underscoring its scale and market impact. Its product portfolio spans innovative and generic drugs, alongside healthcare services, positioning it as a key contributor to the health industry. The company's strategic emphasis on R&D and manufacturing excellence solidifies its role in delivering essential medical treatments and advancing healthcare solutions worldwide.